Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study-Reference-Cited by-同舟云学术

Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study

Published:2021-08 Issue:4 Volume:6 Page:100191
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Hotta K.,Saeki S.,Yamaguchi M.,Harada D.,Bessho A.,Tanaka K.,Inoue K.,Gemba K.,Shiojiri M.,Kato Y.,Ninomiya T.,Kubo T.,Kishimoto J.,Shioyama Y.,Katsui K.,Sasaki J.,Kiura K.,Sugio K.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference25 articles.

1. Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007;Segawa;J Clin Oncol,2010

2. PROCLAIM: randomized phase III trial of pemetrexed-cisplatin or etoposide-cisplatin plus thoracic radiation therapy followed by consolidation chemotherapy in locally advanced nonsquamous non-small-cell lung cancer;Senan;J Clin Oncol,2016

3. Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non-small-cell lung cancer: West Japan Thoracic Oncology Group WJTOG0105;Yamamoto;J Clin Oncol,2010

4. Impact of HER2 gene and protein status on the treatment outcome of cisplatin-based chemoradiotherapy for locally advanced non-small cell lung cancer;Kuyama;J Thorac Oncol,2008

5. A phase II study of cisplatin plus S-1 with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancer: the Okayama Lung Cancer Study Group Trial 0501;Nogami;Lung Cancer,2015

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiotherapy and immunology;Journal of Experimental Medicine;2024-05-21

2. The ASCENT Trial: a phase 2 study of induction and consolidation afatinib and chemoradiation with or without surgery in stage III EGFR-mutant NSCLC;The Oncologist;2024-05-18

3. Radiotherapy combined with EGFR-TKIs for stage III EGFR-Mutated lung cancer: A retrospective cohort study;2024-03-15

4. Targeted treatment for unresectable EGFR mutation-positive stage III non-small cell lung cancer: Emerging evidence and future perspectives;Lung Cancer;2024-01

5. Perioperative Treatment in Egfr-Mutant Early-Stage Non-Small Cell Lung Cancer: Current Evidence and Future Perspectives;2024